The DOI matches its Crossref record; 86 of the 86 references it cites were found in a registry or an index.
Class A carbapenemases
Abstract
Carbapenems, such as imipenem and meropenem, are most often used to treat infections caused by enterobacteria that produce extended-spectrum beta-lactamases, and the emergence of enzymes capable of inactivating carbapenems would therefore limit the options for treatment. Carbapenem resistance in Enterobacteriaceae is rare, but class A beta-lactamases with activity against the carbapenems are becoming more prevalent within this bacterial family. The class A carbapenemases can phylogenetically be segregated into six different groups of which four groups are formed by members of the GES, KPC, SME, IMI/NMC-A enzymes, while SHV-38 and SFC-1 each separately constitute a group. The genes encoding the class A carbapenemases are either plasmid-borne or located on the chromosome of the host. The bla(GES) genes reside as gene cassettes on mainly class I integrons, whereas the bla(KPC) genes and a single bla(IMI-2) gene are flanked by transposable elements on plasmids. Class A carbapenemases hydrolyse penicillins, classical cephalosporins, monobactam, and imipenem and meropenem, and the enzymes are divided into four phenotypically different groups, namely group 2br, 2be, 2e and 2f, according to the Bush-Jacoby-Medeiros classification system. Class A carbapenemases are inhibited by clavulanate and tazobactam like other class A beta-lactamases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A functional classification scheme for beta-lactamases and its correlation with molecular structure
Bush, K., Jacoby, G. A., & Medeiros, A. A. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.6.1211 · Cited by 2,475
Ambler, R. P. (1980) · Philosophical Transactions of the Royal Society of London. B, Biological Sciences · doi:10.1098/rstb.1980.0049 · Cited by 1,823
Inactivation of Antibiotics and the Dissemination of Resistance Genes
Davies, J. (1994) · Science · doi:10.1126/science.8153624 · Cited by 1,730
Yigit, H., Queenan, A. M., Anderson, G. J., Domenech-Sanchez, A., Biddle, J. W., Steward, C. D., Alberti, S., Bush, K., & Tenover, F. C. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.4.1151-1161.2001 · Cited by 1,639
Metallo-β-Lactamases: the Quiet before the Storm?
Walsh, T. R., Toleman, M. A., Poirel, L., & Nordmann, P. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.2.306-325.2005 · Cited by 1,431
A standard numbering scheme for the class A β-lactamases
Ambler, R. P., Coulson, A. F. W., Frère, J. M., Ghuysen, J. M., Joris, B., Forsman, M., Levesque, R. C., Tiraby, G., & Waley, S. G. (1991) · Biochemical Journal · doi:10.1042/bj2760269 · Cited by 1,073
Masuda, N., Sakagawa, E., Ohya, S., Gotoh, N., Tsujimoto, H., & Nishino, T. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.12.3322-3327.2000 · Cited by 722
Evolution and Dissemination of β-Lactamases Accelerated by Generations of β-Lactam Antibiotics
Medeiros, A. A. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.supplement_1.s19 · Cited by 587
Bratu, S., Landman, D., Haag, R., Recco, R., Eramo, A., Alam, M., & Quale, J. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.12.1430 · Cited by 573
KAHAN, J. S., KAHAN, F. M., GOEGELMAN, R., CURRIE, S. A., JACKSON, M., STAPLEY, E. O., MILLER, T. W., MILLER, A. K., HENDLIN, D., MOCHALES, S., et al. (1979) · The Journal of Antibiotics · doi:10.7164/antibiotics.32.1 · Cited by 514
Walther-Rasmussen, J., & Høiby, N. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki482 · Cited by 495
Self-citationBradford, P. A., Bratu, S., Urban, C., Visalli, M., Mariano, N., Landman, D., Rahal, J. J., Brooks, S., Cebular, S., & Quale, J. (2004) · Clinical Infectious Diseases · doi:10.1086/421495 · Cited by 485
Woodford, N., Tierno, P. M., Young, K., Tysall, L., Palepou, M.-F. I., Ward, E., Painter, R. E., Suber, D. F., Shungu, D., Silver, L. L., et al. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.12.4793-4799.2004 · Cited by 442
Poirel, L., Le Thomas, I., Naas, T., Karim, A., & Nordmann, P. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.3.622-632.2000 · Cited by 421
Quale, J., Bratu, S., Gupta, J., & Landman, D. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.5.1633-1641.2006 · Cited by 409
Of Pseudomonas, porins, pumps and carbapenems
Livermore, D. M. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/47.3.247 · Cited by 391
Jaurin, B., & Grundström, T. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.8.4897 · Cited by 390
Paterson, D. L. (2000) · Clinical Microbiology and Infection · doi:10.1046/j.1469-0691.2000.00107.x · Cited by 310
Bratu, S., Tolaney, P., Karumudi, U., Quale, J., Mooty, M., Nichani, S., & Landman, D. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki175 · Cited by 307
Villegas, M. V., Lolans, K., Correa, A., Kattan, J. N., Lopez, J. A., & Quinn, J. P. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01405-06 · Cited by 293
Bratu, S., Mooty, M., Nichani, S., Landman, D., Gullans, C., Pettinato, B., Karumudi, U., Tolaney, P., & Quale, J. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.7.3018-3020.2005 · Cited by 246
ARI 1: β-lactamase-mediated imipenem resistance in Acinetobacter baumannii
Paton, R., Miles, R. S., Hood, J., Amyes, S. G. B., Miles, R. S., & Amyes, S. G. B. (1993) · International Journal of Antimicrobial Agents · doi:10.1016/0924-8579(93)90045-7 · Cited by 245
Plasmid-mediated, carbapenem-hydrolysing beta-lactamase, KPC-2, in Klebsiella pneumoniae isolates
Smith Moland, E. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg124 · Cited by 245
Virginia Villegas, M., Lolans, K., Correa, A., Jose Suarez, C., Lopez, J. A., Vallejo, M., & Quinn, J. P. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00186-06 · Cited by 232
GES-2, a Class A β-Lactamase from Pseudomonas aeruginosa with Increased Hydrolysis of Imipenem
Poirel, L., Weldhagen, G. F., Naas, T., De Champs, C., Dove, M. G., & Nordmann, P. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.9.2598-2603.2001 · Cited by 228
Rasmussen, B. A., Bush, K., Keeney, D., Yang, Y., Hare, R., O'Gara, C., & Medeiros, A. A. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.9.2080 · Cited by 217
Carbapenem Resistance Mechanisms in Pseudomonas aeruginosa Clinical Isolates
Pai, H., Kim, J.-W., Kim, J., Lee, J. H., Choe, K. W., & Gotoh, N. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.2.480-484.2001 · Cited by 205
Plasmid-Mediated KPC-2 in a Klebsiella pneumoniae Isolate from China
Wei, Z.-Q., Du, X.-X., Yu, Y.-S., Shen, P., Chen, Y.-G., & Li, L.-J. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01053-06 · Cited by 205
Carbapenem Resistance in Klebsiella pneumoniae Not Detected by Automated Susceptibility Testing
Tenover, F. C., Kalsi, R. K., Williams, P. P., Carey, R. B., Stocker, S., Lonsway, D., Rasheed, J. K., Biddle, J. W., McGowan, J. E., & Hanna, B. (2006) · Emerging Infectious Diseases · doi:10.3201/eid1208.060291 · Cited by 199
Naas, T., Nordmann, P., Vedel, G., & Poyart, C. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.10.4423-4424.2005 · Cited by 190
OXA β-lactamases in Acinetobacter: the story so far
Brown, S., & Amyes, S. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki425 · Cited by 189
Miriagou, V., Tzouvelekis, L. S., Rossiter, S., Tzelepi, E., Angulo, F. J., & Whichard, J. M. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.4.1297-1300.2003 · Cited by 188
Carbapenem-Resistant Strain of Klebsiellaoxytoca Harboring Carbapenem-Hydrolyzingβ-LactamaseKPC-2
Yigit, H., Queenan, A. M., Rasheed, J. K., Biddle, J. W., Domenech-Sanchez, A., Alberti, S., Bush, K., & Tenover, F. C. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.12.3881-3889.2003 · Cited by 187
Naas, T., Vandel, L., Sougakoff, W., Livermore, D. M., & Nordmann, P. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.6.1262 · Cited by 184
Deshpande, L. M., Jones, R. N., Fritsche, T. R., & Sader, H. S. (2006) · Microbial Drug Resistance · doi:10.1089/mdr.2006.12.223 · Cited by 169
Diversity and Evolution of the Class A Chromosomal Beta-Lactamase Gene in Klebsiella pneumoniae
Hæggman, S., Löfdahl, S., Paauw, A., Verhoef, J., & Brisse, S. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.7.2400-2408.2004 · Cited by 164
Yang, Y. J., Wu, P. J., & Livermore, D. M. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.5.755 · Cited by 163
Carbapenemase-producingEnterobacteriaceae, U.S. Rivers
Aubron, C., Poirel, L., Ash, R. J., & Nordmann, P. (2005) · Emerging infectious diseases · doi:10.3201/eid1102.030684 · Cited by 162
Nordmann, P., Mariotte, S., Naas, T., Labia, R., & Nicolas, M. H. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.5.939 · Cited by 161
Navon-Venezia, S., Chmelnitsky, I., Leavitt, A., Schwaber, M. J., Schwartz, D., & Carmeli, Y. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00438-06 · Cited by 160
Naas, T., & Nordmann, P. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.16.7693 · Cited by 159
Sequence of PSE-2 beta-lactamase
Huovinen, P., Huovinen, S., & Jacoby, G. A. (1988) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.32.1.134 · Cited by 150
Deshpande, L. M., Rhomberg, P. R., Sader, H. S., & Jones, R. N. (2006) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2006.07.004 · Cited by 149
Mena, A., Plasencia, V., García, L. M., Hidalgo, O., Ayestarán, I., Albertí, S., Borrell, N., Pérez, J. L., & Oliver, A. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.00418-06 · Cited by 148
Molecular Characterization of a New Class 3 Integron in Klebsiella pneumoniae
Correia, M. O. A., Boavida, F., Grosso, F., Salgado, M. J., Lito, L., Melo‐Cristino, J., Mendo, S., & Duarte, A. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.9.2838-2843.2003 · Cited by 135
Karlowsky, J. A., Jones, M. E., Thornsberry, C., Friedland, I. R., & Sahm, D. F. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.5.1672-1680.2003 · Cited by 135
Detection of KPC Carbapenem-Hydrolyzing Enzymes in Enterobacter spp. from Brooklyn, New York
Bratu, S., Landman, D., Alam, M., Tolentino, E., & Quale, J. M. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.776-778.2005 · Cited by 133
Queenan, A. M., Torres‐Viera, C., Gold, H. S., Carmeli, Y., Eliopoulos, G. M., Moellering, R. C., Quinn, J. P., Hindler, J. F., Medeiros, A. A., & Bush, K. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.11.3035-3039.2000 · Cited by 128
Moland, E. S., Hanson, N. D., Black, J. A., Hossain, A., Song, W., & Thomson, K. S. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.00756-06 · Cited by 126
Ryoo, N. H., Kim, E. C., Chong, Y., Park, Y. J., Lee, K., Bae, I. K., Song, E. H., & Jeong, S. H. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki324 · Cited by 124
Yang, Y., Bhachech, N., & Bush, K. (1995) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/35.1.75 · Cited by 123
Bratu, S., Brooks, S., Burney, S. N., Kochar, S., Gupta, J., Landman, D., & Quale, J. M. (2007) · Clinical Infectious Diseases · doi:10.1086/512370 · Cited by 122
Structure of the SHV-1 β-Lactamase
Kuzin, A. P., Nukaga, M., Nukaga, Y., Hujer, A. M., Bonomo, R. A., & Knox, J. R. (1999) · Biochemistry · doi:10.1021/bi990136d · Cited by 121
Plasmid-Mediated Carbapenem-Hydrolyzing Enzyme KPC-2 in an Enterobacter sp
Hossain, A., Ferraro, M. J., Pino, R. M., Dew, R. B., Moland, E. S., Lockhart, T. J., Thomson, K. S., Goering, R. V., & Hanson, N. D. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.11.4438-4440.2004 · Cited by 108
Vourli, S., Giakkoupi, P., Miriagou, V., Tzelepi, Ε., Vatopoulos, A. C., & TZOUVELEKIS, L. S. (2004) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2004.tb09535.x · Cited by 107
Armand-Lefèvre, L., Leflon‐Guibout, V., Bredin, J., Barguellil, F., Amor, A., Pagès, J., & Nicolas-Chanoine, M.-H. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.3.1165-1168.2003 · Cited by 102
Poirel, L. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/49.3.561 · Cited by 102
Giakkoupi, P., TZOUVELEKIS, L. S., Tsakris, A., Loukova, V., Sofianou, D., & Tzelepi, Ε. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.9.2247-2253.2000 · Cited by 100
Szabó, D., Silveira, F. P., Hujer, A. M., Bonomo, R. A., Hujer, K. M., Marsh, J. W., Bethel, C. R., Doi, Y., Deeley, K. B., & Paterson, D. L. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01591-05 · Cited by 95
The Biosynthetic Gene Cluster for the β-Lactam Carbapenem Thienamycin in Streptomyces cattleya
Núñez, L. E., Méndez, C., Braña, A. F., Blanco, G., & Salas, J. A. (2003) · Chemistry & Biology · doi:10.1016/s1074-5521(03)00069-3 · Cited by 93
Imipenem- and meropenem-resistant mutants of Enterobacter cloacae and Proteus rettgeri lack porins
Raimondi, A., Traverso, A., & Nikaido, H. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.6.1174 · Cited by 89
Shimizu‐Ibuka, A., Taguchi, A., Ishiguro, M., et al. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.2432 · Cited by 85
Swarén, P., Maveyraud, L., Raquet, X., Cabantous, S., Duez, C., Pédelacq, J. D., Mariotte-Boyer, S., Mourey, L., Labia, R., Nicolas-Chanoine, M.-H., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.41.26714 · Cited by 85
Hashizume, T., Ishino, F., Nakagawa, J., Tamaki, S., & Matsuhashi, M. (1984) · The Journal of Antibiotics · doi:10.7164/antibiotics.37.394 · Cited by 82
Kinetics Study of KPC-3, a Plasmid-Encoded Class A Carbapenem-Hydrolyzing β-Lactamase
Alba, J., Ishii, Y., Thomson, K. S., Moland, E. S., & Yamaguchi, K. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.11.4760-4762.2005 · Cited by 80
Crowley, B., Benedi, V. J., & Doménech‐Sánchez, A. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.11.3679-3682.2002 · Cited by 79
Imipenem and expression of multidrug efflux pump in Enterobacter aerogenes
Bornet, C., Chollet, R., Malléa, M., Chevalier, J., Davin‐Regli, A., Pagès, J., & Claude Bollet, C. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00074-3 · Cited by 78
Poirel, L., Héritier, C., Podglajen, I., Sougakoff, W., Gutmann, L., & Nordmann, P. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.2.755-758.2003 · Cited by 77
Henriques, I. S., Moura, A., Alves, A., Saavedra, M. J., & Correia, A. C. M. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.6.2321-2324.2004 · Cited by 76
Chow, J. W., & Shlaes, D. M. (1991) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/28.4.499 · Cited by 74
Zhang, R., Zhou, H. W., Cai, J., & Chen, G. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl541 · Cited by 67
Poirel, L., Briñas, L., Fortineau, N., & Nordmann, P. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3593-3597.2005 · Cited by 66
Pasterán, F. G., Faccone, D. F., Petroni, A., Rapoport, M., Galas, M., Vázquez, M., & Procopio, A. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.1.474-475.2005 · Cited by 63
A Pseudomonas aeruginosa isolate producing the GES-5 extended-spectrum -lactamase
Wang, C. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl116 · Cited by 63
Castanheira, M., Mendes, R. E., Walsh, T. R., Gales, A. C., & Jones, R. N. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.6.2344-2345.2004 · Cited by 56
NmcA Carbapenem-hydrolyzing Enzyme inEnterobacter cloacaein North America1
Pottumarthy, S., Moland, E. S., Juretschko, S., Swanzy, S. R., Thomson, K. S., & Fritsche, T. R. (2003) · Emerging infectious diseases · doi:10.3201/eid0908.030096 · Cited by 55
Structure of the imipenem-hydrolyzing class A β-lactamase SME-1 fromSerratia marcescens
Sougakoff, W., L’Hermite, G., Pernot, L., Naas, T., Guillet, V., Nordmann, P., Jarlier, V., & Delettré, J. (2002) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444901019606 · Cited by 52
Majiduddin, F. K., & Palzkill, T. G. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.3.1062-1067.2003 · Cited by 48
Villar, H. (1997) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/40.3.365 · Cited by 44
Amino Acid Residues That Contribute to Substrate Specificity of Class A β-Lactamase SME-1
Majiduddin, F. K., & Palzkill, T. G. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3421-3427.2005 · Cited by 43
First Class A Carbapenemase Isolated from Enterobacteriaceae in Argentina
Radice, M. A., Power, P. P., Gutkind, G., Fernández, K., Vay, C. A., Famiglietti, A. M. R., Ricover, N., & Ayala, J. A. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.3.1068-1069.2004 · Cited by 42
Naas, T., Livermore, D. M., & Nordmann, P. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.3.629 · Cited by 39
A kinetic study of NMC-A β-lactamase, an Ambler class A carbapenemase also hydrolyzing cephamycins
Mariotte-Boyer, S., Nicolas, M. H., & Labia, R. (1996) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1996.tb08457.x · Cited by 37
KPC Type B-Lactamase, Rural Pennsylvania
Pope, J. G., Adams, J. M., Doi, Y., Szabó, D., & Paterson, D. L. (2006) · Emerging infectious diseases · doi:10.3201/eid1210.060297 · Cited by 26
Role of Ser-237 in the substrate specificity of the carbapenem-hydrolyzing class A β-lactamase Sme-1
Sougakoff, W., Naas, T., Nordmann, P., Collatz, E., & Jarlier, V. (1999) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/s0167-4838(99)00138-7 · Cited by 24
Sauvage, E., Fonzé, E., Quinting, B., Galleni, M., Frère, J., & Charlier, P. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01226-05 · Cited by 20
Cited by
Carbapenem resistance in Enterobacteriaceae: here is the storm!
Nordmann, P., Dortet, L., & Poirel, L. (2012) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2012.03.003 · Cited by 1,038
Pseudomonas Aeruginosa: Resistance to the Max
Poole, K. (2011) · Frontiers in Microbiology · doi:10.3389/fmicb.2011.00065 · Cited by 948
Epidemiology of β-Lactamase-Producing Pathogens
Bush, K., & Bradford, P. A. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00047-19 · Cited by 938
Mathers, A. J., Peirano, G., & Pitout, J. D. D. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00116-14 · Cited by 872
Carbapenemase-Producing Klebsiella pneumoniae, a Key Pathogen Set for Global Nosocomial Dominance
Pitout, J. D. D., Nordmann, P., & Poirel, L. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01019-15 · Cited by 852
Metadata
- Authors
- Walther-Rasmussen, J., & Høiby, N.
- Venue
- Journal of Antimicrobial Chemotherapy
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-06-26
- Volume
- 60
- Issue
- 3
- Pages
- 470-482
- ISSN
- 0305-7453 (ISSN-L)
- 1460-2091
- OpenAlex
- W2143378971
- Cited by
- 271
- References
- 86
- FWCI
- 8.79
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.